why choose us

First received: August 18, 2023

Clinical Trial: BLOCK-SAH - PPF-Block for Post-SAH Headache

Study Status: Completed

Recruit Status: RECRUITING

Condition: Subarachnoid Hemorrhage, Aneurysmal

Study Type: INTERVENTIONAL


Official Title: Pterygopalatine Fossa (PPF) Block as an Opioid Sparing Treatment for Acute Headache in Aneurysmal Subarachnoid Hemorrhage

Brief Summary: BLOCK-SAH is a phase II, multicenter, randomized, double-blinded, placebo-controlled clinical trial with a sequential parallel comparison design (SPCD) of bilateral pterygopalatine fossa (PPF) injections with 20mg ropivacaine + 4mg dexamethasone (active, PPF-block) compared to saline (placebo) for headache in survivors of aneurysmal subarachnoid hemorrhage (SAH), while monitoring intracranial arterial mean flow velocities with transcranial Doppler (TCD) peri-intervention (intervention = PPF-injections: active or…

Read more